Development and evaluation of lafutidine solid dispersion via hot melt extrusion: Investigating drug-polymer miscibility with advanced characterisation

Asian Journal of Pharmaceutical Sciences

Volumn 9, Issue 2, 2014, Pages 92-106

  Fule, Ritesh ^a   Amin, Purnima ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Atomic force microscopy; Dissolution rate; Hot melt extrusion; Lafutidine; Raman spectroscopy; Solid dispersion

Indexed keywords

LAFUTIDINE; MACROGOL 400; POLOXAMER;

ARTICLE; ATOMIC FORCE MICROSCOPY; DISPERSION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MISCIBILITY; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; SIMULATION; SOLID STATE; X RAY DIFFRACTION;

EID: 84921766233     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2013.12.004     Document Type: Article

References (41)

1. Windbergs M., Strachan C., Kleinebudde P. Influence of structural variations on drug release from lipid/polyethylene glycol matrices. Eur J Pharm Sci 2009, 37:555-562.
2. Fule R., Meer T., Amin P., Dhamecha D., Ghadlinge S. Preparation and characterisation of lornoxicam solid dispersion systems using hot melt extrusion technique. J Pharm Invest 2013, 43(5). [Article online].
3. Vithani K., Maniruzzamana M., Slippera I., et al. Sustained release solid lipid matrices processed by hot-melt extrusion. Coll Surf B: Biointerfaces 2013, 110:403-410.
4. Djuris J., Nikolakakis I., Ibricaet S., et al. Preparation of carbamazepine-Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm 2013, 84:228-237.
5. Fule R., Meer T., Sav A., Amin P. Artemether-Soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristics. J Pharm 2013, 1:1-15.
6. Chokshi R.J., Zia H., Sandhu H.K., et al. Improving the dissolution rate of poorly water soluble drug by SD and solid solution: pros and cons. Drug Del 2007, 4:33-45.
7. Tho I., Liepold B., Rosenberg J., et al. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci 2010, 40:25-32.
8. Stella V.J., Nti-Addae K.W. Prodrug strategies to overcome poor water solubility. Adv Drug Del Rev 2007, 59:677-694.
9. Fule R., Meer T., Sav A., Amin P. Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation. J Pharm Invest 2013, 43:305-321.
10. Sarode A., Sandhu H., Shah N., et al. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur J Pharm Sci 2013, 48:371-384.
11. Itoh H., Naito T., Takeyama M. Lafutidine changes levels of somatostatin, calcitonin gene-related peptide, and secretin in human plasma. Bio Pharm Bull 2002, 25:379-382.
12. Vasconcelos T., Sarmento B., Costa P. SD as strategy to improve oral bioavailability of poorly water soluble drugs. Drug Disc Today 2007, 12:1068-1075.
13. Kalogeras I.M. A novel approach for analysing glass-transition temperature vs. composition patterns: application to pharmaceutical compound + polymer systems. Eur J Pharm Sci 2011, 42:470-483.
14. Konno H., Taylor L.S. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 2006, 95:2692-2705.
15. Zsombor K.N., Attila B., Vajna B., et al. Comparison of electrospun and extruded soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci 2012, 101:322-332.
16. Fule R., Meer T., Sav A., Amin P. Dissolution rate enhancement and physicochemical characterization of artemether and lumefantrine solid dispersions. Int J Drug Del 2012, 4:95-106.
17. Greenhalgh D.J., Williams A.C., Timmins P.Y., et al. Solubility parameters as predictors of miscibility in SD. J Pharm Sci 1999, 88:1182-1190.
18. Dukeck R., Sieger P., Karmwar P. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective. Eur J Pharm Sci 2013, 49:723-731.
19. Marsac P.J., Shamblin S.L., Taylor L.S. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006, 23:2417-2426.
20. Linn M., Collnot E.M., Djuric D., et al. Soluplus® as an effective absorption enhancer of poorly soluble drugs invitro. Eur J Pharm Sci 2012, 45:336-343.
21. Osama A.A., David S.J., Andrews G.P. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods. J Pharm Sci 2012, 101:200-213.
22. Forster A., Hempenstall J., Tucker I., et al. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 2001, 226:147-161.
23. Andrews G.P., Osama A.D., Kusmanto F., et al. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmac 2010, 62:1580-1590.
24. Widjaja E., Kanaujia P., Lau G., et al. Detection of trace crystallinity in an amorphous system using Raman microscopy and geometric analysis. Eur J Pharm Sci 2011, 42:45-54.
25. Negi J., Chattopadhyay P., Sharma A.K., et al. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self-nano-emulsification (SNE) technique. Eur J Pharm Sci 2013, 48:231-239.
26. Maniruzzaman M., Morgan D.J., Mendham A.P., et al. Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 2013, 443:199-208.
27. Machackova M., Tokarsky J., Capkova P. A simple molecular modelling method for the characterization of polymeric drug carriers. Eur J Pharm Sci 2013, 48:316-322.
28. Zhou P., Xie X., Knight D.P., et al. Effects of pH and calcium ions on the conformational transitions in silk fibroin using 2D Raman correlation spectroscopy and 13C solid-state NMR. Biochemistry 2004, 43:11302-11311.
29. Sumithra M., Sundaram P., Srinivasulu K. Analytical method development and validation of LAFT in tablet dosage form by RP-HPLC. Int J Chem Tech Res 2011, 3:1403-1407.
30. Parekh R., Patel P., Patel C., et al. Development and validation of UV spectrophotometric method for estimation of LAFT in bulk and pharmaceutical dosage form. Int J Drug Dev Res 2012, 4:325-329.
31. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002, 54:107-117.
32. Weuts I., Kempen D., Decorte A., et al. Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci 2004, 22:375-385.
33. Jung J.Y., Yoo S.D., Lee S.H., et al. Enhanced solubility and dissolution rate of itraconazole by an SD technique. Int J Pharm 1999, 187:209-218.
34. Leuner C., Dressman J. Improving drug solubility for oral delivery using SD. Eur J Pharm Biopharm 2000, 50:47-60.
35. Saerens L., Dierickx L., Lenain B., et al. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. Eur J Pharm Biopharm 2011, 77:158-163.
36. Lauer M., Siam M., Tardio J., et al. Rapid assessment of homogeneity and stability of amorphous solid dispersions by atomic force microscopy-from bench to batch. Pharm Res 2013, 30:2010-2022.
37. Almeida A., Saerens L., De Beer T., et al. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Int J Pharm 2012, 439:223-229.
38. Natalija Z., Obrezaa A., Bele M., et al. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm 2005, 291:51-58.
39. Fu J., Zhang L., Tingting G., et al. Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Tech 2010, 204:214-221.
40. Yang J., Gray K., Doney J., et al. An improved kinetics approach to describe the physical stability of amorphous SD. Int J Pharm 2010, 384:24-31.
41. Sathigari S.K., Radhakrishnan V.K., Davis V.A., et al. Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement. J Pharm Sci 2012, 101:3456-3464.